Income Statement APTOCROM Inc.

Stocks

A109960

KR7109960005

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 2026-08-04			5-day change	1st Jan Change
1,650.00 ^KRW	-0.06%		+1.41%	-67.00%

06-30	Aprogen Biologics Inc. announced that it has received KRW 50.8 billion in funding from APTOCROM Inc.	CI
05-25	Aprogen Biologics Inc. announced that it expects to receive KRW 50.8 billion in funding from APTOCROM Inc.	CI

3fd0ccd94d1d3f.LdYwyE55_mPQEQzrSfdWyiegTkMSDqERbHidq0-pCbE.a7hl-CsUsCyVS2-YZJsRrFTYOQteI-wgLg3SnR2cZfZXkQf6DU6dBYpkVQ

Published financial data: APTOCROM INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	8.42B	9.6B	16.01B	16.4B	9.81B
Other Revenues, Total	-	-10	-10	-10	-
Total Revenues	8.42B	9.6B	16.01B	16.4B	9.81B
Cost of Goods Sold, Total	6.7B	7.49B	11.05B	11.08B	8.34B
Gross Profit	1.71B	2.11B	4.96B	5.32B	1.47B
Selling General & Admin Expenses, Total	4.04B	2.88B	3.8B	3.46B	3.29B
Provision for Bad Debts	-20.5M	11.2B	21.21B	491M	14.35B
R&D Expenses	-	-	794M	783M	493M
Depreciation & Amortization - (IS)	134M	55.35M	94.05M	21.96M	14.94M
Amortization of Goodwill and Intangible Assets - (IS)	52.98M	7.51M	6.72M	2.26M	588K
Other Operating Expenses	86.79M	59.11M	59.78M	52.02M	49.83M
Other Operating Expenses, Total	4.29B	14.21B	25.96B	4.81B	18.2B
Operating Income	-2.58B	-12.1B	-21B	517M	-16.74B
Interest Expense, Total	-6.72M	-64.4M	-2.13B	-4.87B	-854M
Interest And Investment Income	3.55B	4.09B	4.07B	12.54B	15.82B
Net Interest Expenses	3.55B	4.02B	1.94B	7.68B	14.96B
Income (Loss) On Equity Invest.	352M	94.73M	-	-	-
Currency Exchange Gains (Loss)	4.95M	-6.48M	27.39M	2.96M	1.66M
Other Non Operating Income (Expenses)	64.82M	111M	-7.52B	-26.84B	6.01B
EBT, Excl. Unusual Items	1.39B	-7.88B	-26.56B	-18.64B	4.24B
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	1.33B	2.63B	32.16B	-7.71B	-4.15B
Gain (Loss) On Sale Of Assets	21.7M	-12.85M	408K	4.28M	631K
Asset Writedown	-95.85M	-	-16.56M	-	-20.23M
Other Unusual Items	-	-	-	-	-6.5B
EBT, Incl. Unusual Items	2.65B	-5.26B	5.58B	-26.34B	-6.43B
Income Tax Expense	-	346M	1.41B	1.68B	-792M
Earnings From Continuing Operations	2.65B	-5.61B	4.17B	-28.02B	-5.63B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	2.65B	-5.61B	4.17B	-28.02B	-5.63B
Minority Interest	2.57M	-	133M	-73.39M	74.88M
Net Income - (IS)	2.65B	-5.61B	4.3B	-28.09B	-5.56B
Net Income to Common Incl Extra Items	2.65B	-5.61B	4.3B	-28.09B	-5.56B
Net Income to Common Excl. Extra Items	2.65B	-5.61B	4.3B	-28.09B	-5.56B
Per Share Items
Net EPS - Basic	1.48K	-3.14K	1.61K	-4.92K	-526.55
Basic EPS - Continuing Operations	1.48K	-3.14K	1.61K	-4.92K	-526.55
Basic Weighted Average Shares Outstanding	1.79M	1.79M	2.67M	5.71M	10.56M
Net EPS - Diluted	1.48K	-3.14K	648.47	-4.92K	-526.55
Diluted EPS - Continuing Operations	1.48K	-3.14K	648.47	-4.92K	-526.55
Diluted Weighted Average Shares Outstanding	1.79M	1.79M	2.85M	5.71M	10.56M
Normalized Basic EPS	487.97	-2.76K	-6.17K	-2.05K	258.1
Normalized Diluted EPS	487.97	-2.76K	-5.77K	-2.05K	258.1
Supplemental Items
EBITDA	-2.17B	-11.81B	-20.45B	948M	-16.37B
EBITA	-2.53B	-12.09B	-21B	520M	-16.74B
EBIT	-2.58B	-12.1B	-21B	517M	-16.74B
EBITDAR	-2.16B	-11.8B	-20.45B	969M	-16.36B
Effective Tax Rate - (Ratio)	-	-6.57	25.21	-6.38	12.32
Normalized Net Income	871M	-4.92B	-16.47B	-11.72B	2.73B
Supplemental Operating Expense Items
Advertising Expense	780M	21.49M	18.38M	16.36M	20.3M
Selling and Marketing Expenses	1.58B	1.18B	1.4B	1.28B	1.1B
General and Administrative Expenses	24.01M	11.03M	15.7M	8.6M	9.76M
Research And Development Expense From Footnotes	-	-	794M	783M	493M
Net Rental Expense, Total	10.08M	7.87M	7.41M	20.93M	12.44M
Imputed Operating Lease Interest Expense	1.38M	796K	10.65M	51.99M	7.13M
Imputed Operating Lease Depreciation	8.7M	7.07M	-3.24M	-31.07M	5.31M
Maintenance & Repair Expenses, Total	48.07M	23.04M	20.97M	40.91M	11.19M
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	11.53B	15.81B	9.22B	4.69B	4.13B
Short Term Investments	30B	390M	1B	2.5B	1B
Trading Asset Securities, Total	14.86B	75.07B	-	35.47B	18.31B
Total Cash And Short Term Investments	56.39B	91.27B	10.22B	42.66B	23.44B
Accounts Receivable, Total	2.34B	4.03B	3.95B	5.06B	3.71B
Other Receivables	1.92B	2.49B	1.93B	2.41B	3.24B
Notes Receivable	50B	7B	714M	878M	2.89B
Total Receivables	54.27B	13.53B	6.6B	8.35B	9.84B
Inventory	739M	1.33B	1.98B	1.44B	1.39B
Prepaid Expenses	1.51M	66.3M	45.03M	18.2M	12.17M
Other Current Assets, Total	837M	1.79B	1.39B	203M	96.34M
Total Current Assets	112B	108B	20.23B	52.67B	34.77B
Gross Property Plant And Equipment	381M	8.13B	8.29B	8.4B	8.48B
Accumulated Depreciation	-226M	-3.77B	-3.96B	-3.8B	-3.88B
Net Property Plant And Equipment	155M	4.37B	4.34B	4.6B	4.6B
Long-term Investments	84.18B	35.73B	223B	154B	192B
Goodwill	-	-	-	-	-
Other Intangibles, Total	16.96M	9.45M	5.67M	2.3M	1.72M
Accounts Receivable Long-Term	20.58B	19.4B	18.17B	16.12B	14.83B
Loans Receivable Long-Term	-	36.49B	42.39B	63.89B	62.67B
Deferred Tax Assets Long-Term	-	-	-	-	2.7B
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	9.58B	9.41B	8.89B	43.65B	8.4B
Total Assets	227B	213B	317B	335B	320B
Liabilities
Accounts Payable, Total	1.86B	1.35B	1.1B	1.12B	792M
Accrued Expenses, Total	119M	156M	276M	487M	133M
Short-term Borrowings	170M	9.65B	13.63B	17.55B	6.18B
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	38.8M	208M	86.22M	30.58M	36.38M
Unearned Revenue Current, Total	120M	-	-	-	-
Other Current Liabilities	809M	646M	12.22B	11.94B	4.57B
Total Current Liabilities	3.12B	12B	27.31B	31.13B	11.71B
Long-Term Debt	-	-	-	-	-
Long-Term Leases	37.5M	89.5M	16.39M	19.78M	29.72M
Pension & Other Post Retirement Benefits	694M	1.09B	1.25B	1.16B	1.39B
Deferred Tax Liability Non Current	-	149M	149M	222M	258M
Other Non Current Liabilities	655M	619M	566M	511M	495M
Total Liabilities	4.5B	13.96B	29.29B	33.04B	13.89B
Common Stock, Total	89.35B	89.35B	57.08B	100B	110B
Additional Paid In Capital	148B	148B	257B	256B	256B
Retained Earnings	-12.29B	-17.97B	-10.58B	-38.68B	-44.29B
Treasury Stock	-419M	-419M	-423M	-423M	-423M
Comprehensive Income and Other	-1.69B	-19.74B	-16.21B	-15.07B	-14.63B
Total Common Equity	223B	199B	287B	302B	307B
Minority Interest	-376M	551M	-34.34M	47.96M	-24.27M
Total Equity	222B	199B	287B	302B	307B
Total Liabilities And Equity	227B	213B	317B	335B	320B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.79M	1.79M	5.71M	10.04M	11.04M
ECS Total Common Shares Outstanding	1.79M	1.79M	5.71M	10.04M	11.04M
Book Value / Share	125K	111K	50.35K	30.07K	27.78K
Tangible Book Value	223B	199B	287B	302B	307B
Tangible Book Value Per Share	125K	111K	50.35K	30.07K	27.78K
Total Debt	246M	9.94B	13.73B	17.6B	6.24B
Net Debt	-56.15B	-81.33B	3.51B	-25.07B	-17.19B
Debt Equivalent Oper. Leases	80.62M	62.94M	59.25M	167M	99.49M
Minority Interest, Total (Incl. Fin. Div)	-376M	551M	-34.34M	47.96M	-24.27M
Equity Method Investments, Total	1.14B	-	-	-	-
Inventories - Raw Materials, Total	-	1.23B	1.1B	981M	979M
Inventories - Work In Process, Total	-	55.51M	19.23M	30.65M	21.91M
Inventories - Finished Goods, Total	846M	640M	867M	434M	494M
Inventories - Others	-20	-450	150	160	-
Land - (BS)	-	1.89B	1.99B	2.34B	2.45B
Buildings, Total	-	2.11B	2.36B	2.36B	2.36B
Machinery, Total	226M	3.51B	3.51B	3.58B	3.6B
Accumulated Allowance for Doubtful Accounts (Supple)	242M	314M	326M	368M	268M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	2.65B	-5.61B	4.3B	-28.09B	-5.56B
Depreciation & Amortization - CF	360M	281M	543M	428M	364M
Amortization of Goodwill and Intangible Assets - (CF)	52.98M	7.51M	6.72M	2.26M	588K
Depreciation & Amortization, Total	413M	289M	550M	430M	365M
(Gain) Loss From Sale Of Asset	-21.7M	12.85M	-407K	-4.28M	-631K
(Gain) Loss on Sale of Investments - (CF)	-1.37B	-1.37B	-32.16B	7.71B	4.15B
Asset Writedown & Restructuring Costs	95.85M	-	16.56M	-	20.23M
(Income) Loss On Equity Investments - (CF)	-352M	-1.35B	-	-	-
Provision and Write-off of Bad Debts	-20.5M	35.94M	-356M	-3.24B	-2.94B
Other Operating Activities, Total	95.74M	11.15B	29.17B	27.45B	5.89B
Change In Accounts Receivable	217M	-297M	173M	247M	11.07M
Change In Inventories	261M	206M	-354M	449M	-116M
Change In Accounts Payable	-190M	-600M	-252M	27.37M	-332M
Change In Income Taxes	-	-	-	-	-223M
Change in Other Net Operating Assets	-15.07B	14.82B	569M	-267M	1.17B
Cash from Operations	-13.29B	17.28B	1.66B	4.71B	2.44B
Capital Expenditure	-5.72M	-	-24.98M	-81.9M	-14.09M
Sale of Property, Plant, and Equipment	24.61M	-	-	3.5M	-
Cash Acquisitions	-	-	-	-	-
Divestitures	-	1.41B	-	-	-
Sale (Purchase) of Intangible assets	82.81M	-	-2.94M	-	-
Investment in Marketable and Equity Securities, Total	-20.52B	-1B	-79.69B	28.6B	10.97B
Net (Increase) Decrease in Loans Originated / Sold - Investing	13.57B	-18.88B	-17.53B	-45.46B	-1.02B
Other Investing Activities, Total	60M	120K	-900K	-34.98B	-1.12B
Cash from Investing	-6.79B	-18.47B	-97.25B	-51.92B	8.82B
Short Term Debt Issued, Total	-	5.5B	7B	-	-
Long-Term Debt Issued, Total	-	-	39.58B	-	-
Total Debt Issued	-	5.5B	46.58B	-	-
Short Term Debt Repaid, Total	-	-	-11B	-	-
Long-Term Debt Repaid, Total	-95.59M	-41.1M	-187M	-90.96M	-21.76B
Total Debt Repaid	-95.59M	-41.1M	-11.19B	-90.96M	-21.76B
Issuance of Common Stock	-	-	55.01B	43.32B	10B
Repurchase of Common Stock	-	-	-3.92M	-	-
Other Financing Activities, Total	-	-10	-1.4B	-542M	-52.77M
Cash from Financing	-95.59M	5.46B	89B	42.69B	-11.82B
Foreign Exchange Rate Adjustments	3.28M	265K	1.17M	-806K	-291K
Miscellaneous Cash Flow Adjustments	-10	-	20	-	-
Net Change in Cash	-20.17B	4.28B	-6.59B	-4.53B	-564M
Supplemental Items
Cash Interest Paid	72.87M	45.17M	516M	959M	441M
Cash Income Tax Paid (Refund)	199M	116M	1.5B	740M	1.71B
Levered Free Cash Flow	11.96B	31.06B	4.21B	-2.42B	-20.02B
Unlevered Free Cash Flow	11.96B	31.1B	5.54B	626M	-19.48B
Change In Net Working Capital	-13.08B	-38.37B	-18.15B	46.3M	9.37B
Net Debt Issued / Repaid	-95.59M	5.46B	35.39B	-90.96M	-21.76B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-0.7	-3.44	-4.88	0.1	-3.19
Return on Total Capital	-0.71	-3.5	-5.06	0.1	-3.31
Return On Equity %	1.17	-2.66	1.69	-9.51	-1.85
Return on Common Equity	1.17	-2.66	1.74	-9.54	-1.83
Margin Analysis
Gross Profit Margin %	20.37	21.95	30.99	32.46	14.96
SG&A Margin	48.01	30	23.74	21.08	33.59
EBITDA Margin %	-25.75	-123.04	-127.78	5.78	-166.93
EBITA Margin %	-30.02	-125.97	-131.18	3.17	-170.65
EBIT Margin %	-30.65	-126.05	-131.22	3.15	-170.66
Income From Continuing Operations Margin %	31.45	-58.41	26.06	-170.86	-57.45
Net Income Margin %	31.49	-58.41	26.89	-171.3	-56.69
Net Avail. For Common Margin %	31.49	-58.41	26.89	-171.3	-56.69
Normalized Net Income Margin	10.35	-51.28	-102.89	-71.48	27.79
Levered Free Cash Flow Margin	142.08	323.63	26.32	-14.73	-204.11
Unlevered Free Cash Flow Margin	142.13	324.05	34.63	3.81	-198.66
Asset Turnover
Asset Turnover	0.04	0.04	0.06	0.05	0.03
Fixed Assets Turnover	31.19	4.25	3.68	3.67	2.13
Receivables Turnover (Average Receivables)	3.32	3.01	4.01	3.64	2.24
Inventory Turnover (Average Inventory)	7.26	7.24	6.68	6.49	5.91
Short Term Liquidity
Current Ratio	36.03	9	0.74	1.69	2.97
Quick Ratio	19.47	8.15	0.59	1.61	2.59
Operating Cash Flow to Current Liabilities	-4.27	1.44	0.06	0.15	0.21
Days Sales Outstanding (Average Receivables)	109.9	121.29	91.05	100.58	163.2
Days Outstanding Inventory (Average Inventory)	50.26	50.41	54.61	56.36	61.79
Average Days Payable Outstanding	108.54	72.42	38.18	38.58	42.18
Cash Conversion Cycle (Average Days)	51.62	99.28	107.48	118.36	182.81
Long Term Solvency
Total Debt/Equity	0.11	4.99	4.78	5.83	2.04
Total Debt / Total Capital	0.11	4.75	4.56	5.51	2
LT Debt/Equity	0.02	0.04	0.01	0.01	0.01
Long-Term Debt / Total Capital	0.02	0.04	0.01	0.01	0.01
Total Liabilities / Total Assets	1.99	6.54	9.25	9.86	4.33
EBIT / Interest Expense	-383.9	-187.85	-9.87	0.11	-19.59
EBITDA / Interest Expense	-322.5	-183.37	-9.61	0.19	-19.16
(EBITDA - Capex) / Interest Expense	-323.35	-183.37	-9.62	0.18	-19.18
Total Debt / EBITDA	-0.11	-0.84	-0.67	18.57	-0.38
Net Debt / EBITDA	25.91	6.89	-0.17	-26.45	1.05
Total Debt / (EBITDA - Capex)	-0.11	-0.84	-0.67	20.32	-0.38
Net Debt / (EBITDA - Capex)	25.84	6.89	-0.17	-28.95	1.05
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-18.44	14.04	66.77	2.46	-40.2
Gross Profit, 1 Yr. Growth %	-30.38	22.91	135.42	7.33	-72.44
EBITDA, 1 Yr. Growth %	-10.09K	445.01	442.17	-104.63	-1.83K
EBITA, 1 Yr. Growth %	580.33	378.57	417.94	-102.47	-3.32K
EBIT, 1 Yr. Growth %	587.45	369.04	417.15	-102.46	-3.34K
Earnings From Cont. Operations, 1 Yr. Growth %	-76.06	-311.78	71.62	-771.74	-79.89
Net Income, 1 Yr. Growth %	-76.09	-311.58	77.09	-752.72	-80.21
Normalized Net Income, 1 Yr. Growth %	-57.1	-653.95	-16.41K	-28.82	-123.25
Diluted EPS Before Extra, 1 Yr. Growth %	-76.06	-311.58	-52.32	-859.27	-87.93
Accounts Receivable, 1 Yr. Growth %	-13.91	72.06	-2.05	28.09	-26.73
Inventory, 1 Yr. Growth %	-33.23	79.98	48.51	-27.3	-3.37
Net Property, Plant and Equip., 1 Yr. Growth %	-59.76	2.72K	-0.66	6.06	0.02
Total Assets, 1 Yr. Growth %	-4.28	-5.89	42.96	5.79	-4.31
Tangible Book Value, 1 Yr. Growth %	-3.98	-10.66	38.85	5.05	1.59
Common Equity, 1 Yr. Growth %	-3.97	-10.66	38.84	5.05	1.59
Cash From Operations, 1 Yr. Growth %	-492.52	-230.04	-90.38	183.21	-48.25
Capital Expenditures, 1 Yr. Growth %	-80.91	-	-	227.86	-82.8
Levered Free Cash Flow, 1 Yr. Growth %	-123.34	159.76	-88.32	-157.32	728.82
Unlevered Free Cash Flow, 1 Yr. Growth %	-123.35	160	-84.65	-88.72	-3.21K
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-38.01	-3.56	37.91	30.72	-21.72
Gross Profit, 2 Yr. CAGR %	-48.35	-7.5	70.1	58.96	-45.61
EBITDA, 2 Yr. CAGR %	599.62	2.23K	207.24	-49.88	-10.53
EBITA, 2 Yr. CAGR %	184.27	470.6	188.28	-64.2	-10.72
EBIT, 2 Yr. CAGR %	97.82	467.84	185.35	-64.31	-10.73
Earnings From Cont. Operations, 2 Yr. CAGR %	-37.83	-28.8	25.53	239.54	16.22
Net Income, 2 Yr. CAGR %	-37.36	-28.88	27.45	239.98	13.65
Normalized Net Income, 2 Yr. CAGR %	-43.81	55.68	330.52	977.53	-59.32
Diluted EPS Before Extra, 2 Yr. CAGR %	-37.5	-28.83	-33.9	90.27	-9.89
Accounts Receivable, 2 Yr. CAGR %	-22.8	21.71	29.82	12.01	-3.12
Inventory, 2 Yr. CAGR %	-1.94	9.62	63.49	3.91	-16.19
Net Property, Plant and Equip., 2 Yr. CAGR %	-92.28	236.78	429.13	2.64	2.99
Total Assets, 2 Yr. CAGR %	1.9	-5.09	18.16	22.98	0.61
Tangible Book Value, 2 Yr. CAGR %	2.84	-7.38	13.61	20.77	3.3
Common Equity, 2 Yr. CAGR %	2.84	-7.38	13.6	20.77	3.3
Cash From Operations, 2 Yr. CAGR %	267.14	125.93	-64.64	-47.81	21.06
Capital Expenditures, 2 Yr. CAGR %	-75.62	-	108.97	-	-24.9
Levered Free Cash Flow, 2 Yr. CAGR %	266.97	-22.14	-40.64	-74.13	117.96
Unlevered Free Cash Flow, 2 Yr. CAGR %	298.64	-22.09	-31.92	-86.84	87.47
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-21.77	-24.04	15.76	24.9	0.72
Gross Profit, 3 Yr. CAGR %	-29.85	-31.05	26.29	45.9	-11.37
EBITDA, 3 Yr. CAGR %	26.67	543.74	880.67	-24.09	63.11
EBITA, 3 Yr. CAGR %	52.59	238.17	283.81	-40.97	60.42
EBIT, 3 Yr. CAGR %	67.1	163.78	282.53	-41.47	60.32
Earnings From Cont. Operations, 3 Yr. CAGR %	-32.35	-6.45	-27.75	119.56	32.35
Net Income, 3 Yr. CAGR %	-32.82	-6.02	-27.04	119.68	31.76
Normalized Net Income, 3 Yr. CAGR %	-42.65	21.28	100.91	136.29	199.96
Diluted EPS Before Extra, 3 Yr. CAGR %	-40.65	-6.16	-52.88	49.14	-27.12
Accounts Receivable, 3 Yr. CAGR %	-25.19	0.84	13.21	29.24	-2.77
Inventory, 3 Yr. CAGR %	104.5	20.06	21.3	24.79	1.42
Net Property, Plant and Equip., 3 Yr. CAGR %	-80.91	-44.81	124.19	209.66	1.76
Total Assets, 3 Yr. CAGR %	-1.59	-0.76	10.15	13.88	13.11
Tangible Book Value, 3 Yr. CAGR %	0.91	-1.87	7.41	10.68	14
Common Equity, 3 Yr. CAGR %	0.78	-1.87	7.41	10.68	14
Cash From Operations, 3 Yr. CAGR %	44.97	159.76	-21.12	-29.25	-47.96
Capital Expenditures, 3 Yr. CAGR %	-48.6	-	-5.89	142.82	-
Levered Free Cash Flow, 3 Yr. CAGR %	-7.15	227.05	-56.52	-41.33	-17.83
Unlevered Free Cash Flow, 3 Yr. CAGR %	-4.83	245.71	-52.35	-62.61	-18.6
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-3.04	-3.11	-1.86	-5.62	-1.01
Gross Profit, 5 Yr. CAGR %	30.41	-3.8	-0.02	-3.7	-9.84
EBITDA, 5 Yr. CAGR %	-27.58	22.38	80.55	84.55	276.34
EBITA, 5 Yr. CAGR %	-25.73	20.75	96.81	10.69	114.18
EBIT, 5 Yr. CAGR %	-26.28	19.2	106.98	-4.73	113.74
Earnings From Cont. Operations, 5 Yr. CAGR %	-34.82	4.33	-13.37	32.55	-12.62
Net Income, 5 Yr. CAGR %	-34.95	11.18	-13.21	32.99	-12.89
Normalized Net Income, 5 Yr. CAGR %	-36.07	15.43	28.95	33.55	6.06
Diluted EPS Before Extra, 5 Yr. CAGR %	-52.76	-4.06	-38.04	5.32	-38.93
Accounts Receivable, 5 Yr. CAGR %	10.44	-4.48	-6.74	5.17	6.37
Inventory, 5 Yr. CAGR %	-10.02	143.93	86.99	13.32	4.63
Net Property, Plant and Equip., 5 Yr. CAGR %	-16.75	-25.26	-27.89	-29.26	64.24
Total Assets, 5 Yr. CAGR %	70.77	8.53	5.88	8.93	6.23
Tangible Book Value, 5 Yr. CAGR %	108.58	11.81	5.81	7.47	5.75
Common Equity, 5 Yr. CAGR %	91.51	11.62	5.73	7.47	5.75
Cash From Operations, 5 Yr. CAGR %	6.47	88.07	-17.55	36.7	-6.38
Capital Expenditures, 5 Yr. CAGR %	-54.8	-	-9.92	-3.18	-14.01
Levered Free Cash Flow, 5 Yr. CAGR %	9.8	19.65	-22.36	22.16	-17.14
Unlevered Free Cash Flow, 5 Yr. CAGR %	12.94	22.88	-16.77	-3.63	-17.58